PCRXbenzinga

Pacira BioSciences Announces Phase 1 Data Showing Single Injection Of Gene Therapy PCRX-201 Provides Sustained Pain, Stiffness, And Function Improvement In Knee Osteoarthritis Patients For Up To 3-Years

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on June 11, 2025 by benzinga

    Pacira BioSciences Announces Phase 1 Data Showing Single Injection Of Gene Therapy PCRX-201 Provides Sustained Pain, Stiffness, And Function Improvement In Knee Osteoarthritis Patients For Up To 3-Years | PCRX Stock News | Candlesense